Emerging therapies in management of AMD

Anat Loewenstein, MD, provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.

Anat Loewenstein, MD, chair, Department of Ophthalmology, Tel Aviv Medical Center (Israel), provides an update on the latest developments in emerging therapies for the management of age-related macular d

Related Videos
How to diagnose geographic atrophy earlier
Samsara Vision update: Concerto trial recruiting patients with late-stage AMD
DAVIO trial update: 12-month safety results indicate no serious adverse events, reduced treatment burden
DAVIO trial: 12-month results show favorable safety profile, reduced treatment burden in patients with nAMD
The relationship between outer retinal integrity, subretinal fluid may affect treatment outcomes
AAVIATE: Gene therapy via suprachoroidal drug delivery may lower treatment burden for patients with AMD
Evaluating effect of central subfield thickness, volatility on visual acuity in clinical trials for nAMD
Related Content

Study: Cones in retinal degeneration, believed to be dormant, may retain visual function

March 28th 2023

Unity Biotechnology announces results from Phase 2 ENVISION study of UBX1325 in patients diagnosed with wet AMD

March 27th 2023

COPHy 2023: Debating the value of home monitoring as a management option for AMD

March 25th 2023

Researchers find eye color genes are key for retinal health

March 24th 2023

LumiThera reveals sustained vision improvement for 24 months in dry AMD clinical trial data

March 17th 2023

COPHy 2023 sets stage for evidence-based debates and discussions

March 15th 2023

Study: Cones in retinal degeneration, believed to be dormant, may retain visual function

March 28th 2023

Unity Biotechnology announces results from Phase 2 ENVISION study of UBX1325 in patients diagnosed with wet AMD

March 27th 2023

COPHy 2023: Debating the value of home monitoring as a management option for AMD

March 25th 2023

Researchers find eye color genes are key for retinal health

March 24th 2023

LumiThera reveals sustained vision improvement for 24 months in dry AMD clinical trial data

March 17th 2023

COPHy 2023 sets stage for evidence-based debates and discussions

March 15th 2023

Study: Cones in retinal degeneration, believed to be dormant, may retain visual function

March 28th 2023

Unity Biotechnology announces results from Phase 2 ENVISION study of UBX1325 in patients diagnosed with wet AMD

March 27th 2023

COPHy 2023: Debating the value of home monitoring as a management option for AMD

March 25th 2023

Researchers find eye color genes are key for retinal health

March 24th 2023

LumiThera reveals sustained vision improvement for 24 months in dry AMD clinical trial data

March 17th 2023

COPHy 2023 sets stage for evidence-based debates and discussions

March 15th 2023
© 2023 MJH Life Sciences

All rights reserved.